Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CanSinoBIO(688185) the Revenue is 356.37 M (+32.95%), Beat estimate;the EBIT is 61.88 M (+2415%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.36B32.95%
0.31B16.60%
+0.04B16.35%
EBITExceed expectations
0.06B2415.20%
0.05B2130.26%
+0.01B284.94%
Upcoming earnings report - Q3 FY2026
Available dateOct 28, 2026
Estimate Revenue¥399.29 M
Estimate EBIT¥62.31 M
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf